Insurers said one major driver of higher premiums is the growing popularity of a relatively new class of injectable drugs to ...

The 40%-70% premium hike has raised widespread complaints, but an in-depth look at the sector shows that cost adjustments are ...

U.S. healthcare spending grew 7.5% to $4.9 trillion in 2023, with hospital care and prescription drugs driving costs. Private ...

MassHealth is transitioning coverage for anti-obesity drugs, designating Zepbound as the preferred option starting in January 2025, with Wegovy and Saxenda being discontinued for most adult members.

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Oxygen therapy saves lives, but does it improve quality of life? Dr Holley explores the balance of benefits, burdens, and ...